Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

Sponsor

M.D. Anderson Cancer Center (Other)

Overall Status

Completed

CT.gov ID

NCT00501449

Collaborator

(none)

133

Enrollment

Location

160.8

Actual Duration (Months)

0.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The specific aims of the study include:

Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2.
Evaluate MEN-specific distress as well as adherence to surveillance regimens among adults with MEN1 or MEN2, and identify associated with those outcomes.

Condition or Disease	Intervention/Treatment	Phase
Multiple Endocrine Neoplasia	Behavioral: Questionnaire

Detailed Description

The proposed cross-sectional study is intended to obtain information regarding current surveillance behaviors and other psychosocial outcomes among persons affected by the multiple endocrine neoplasia (MEN) 1 or MEN2, which are inherited conditions.

Study participants will include patients who have been seen previously at MDACC for evaluation of MEN1 or MEN2. Because this is the first time investigators are contacting these patients to invite them to participate in psychosocial research, the proposed study also will help determine the feasibility of conducting similar studies in the future.

Investigators anticipate that data gathered from this study will enhance existing knowledge about the psychological and behavioral aspects of the MEN syndromes, and will inform future research efforts directed toward this understudied population.

Study Design

Study Type:

Observational

Actual Enrollment :

133 participants

Observational Model:

Case-Only

Time Perspective:

Prospective

Official Title:

Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

Actual Study Start Date :

May 1, 2007

Actual Primary Completion Date :

Sep 22, 2020

Actual Study Completion Date :

Sep 22, 2020

Arms and Interventions

Arm	Intervention/Treatment
Multiple Endocrine Neoplasia (MEN) Patients with multiple endocrine neoplasia (MEN).	Behavioral: Questionnaire Mailed packets including cover letter describing purpose of study, study questionnaire, and return envelope. Other Names: Survey

Arm

Intervention/Treatment

Multiple Endocrine Neoplasia (MEN)

Patients with multiple endocrine neoplasia (MEN).

Behavioral: Questionnaire

Mailed packets including cover letter describing purpose of study, study questionnaire, and return envelope.

Other Names:

Survey

Outcome Measures

Primary Outcome Measures

Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2. [3 Years]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Adults age 18 years or older, with a clinical or genetic diagnosis of MEN1 or MEN2
Spouse, Significant Other, or Family Member who is at least 18 years of age and who is related to an individual who is a patient at MDACC and who has been diagnosed with MEN1.
Ability to read and write English